The telehealth platform was hit earlier this year by the Food & Drug Administration declaring there was no longer a shortage of Ozempic or Wegovy, the GLP-1 drugs sold by Novo Nordisk (NYSE:NVO | NVO ...

Telehealth darling Hims & Hers Health Inc (NYSE:HIMS) got slapped with a 34% stock crash on Monday. Novo Nordisk A/S (NYSE:NVO) ended their relationship – and it wasn't amicable. But is the plunge a ...

・The three-day rout was driven by Novo Nordisk’s lawsuit and an FDA crackdown on compounded GLP-1 drugs. ・Deutsche Bank and Canaccord cut price targets on HIMS but pointed to 70%–80% upside from ...

Restaurants are pushing protein and smaller portions to keep attracting those eating less.